RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2008.10.018PMID 18992745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

  2008cited by this paper
• Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis

  2008cited by this paper
• Commensal Gut Flora Drives the Expansion of Proinflammatory CD4 T Cells in the Colonic Lamina Propria under Normal and Inflammatory Conditions1

  2008cited by this paper
• TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

  2008cited by this paper
• Role of the novel Th17 cytokine IL‐17F in inflammatory bowel disease (IBD): Upregulated colonic IL‐17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD

  2008cited by this paper
• IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

  2008cited by this paper
• Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue

  2007cited by this paper
• Mouse models of inflammatory bowel disease.

  2007cited by this paper
• The fundamental basis of inflammatory bowel disease.

  2007cited by this paper
• IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells

  2007cited by this paper
• The development of inflammatory TH-17 cells requires interferon-regulatory factor 4

  2007cited by this paper
• Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner.

  2007cited by this paper
• IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways

  2007cited by this paper
• Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance.

  2007cited by this paper
• Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology.

  2006cited by this paper
• IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.

  2006cited by this paper
• Interleukin-23 drives innate and T cell–mediated intestinal inflammation

  2006cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

  2006cited by this paper
• Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease

  2006cited by this paper
• Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• Critical role of IL‐17 receptor signaling in acute TNBS‐induced colitis

  2006cited by this paper
• High resolution colonoscopy in live mice

  2006cited by this paper
• Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex

  2006cited by this paper
• Interleukin-17 family members and inflammation.

  2004cited by this paper
• Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.

  2004cited by this paper
• Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

  2004cited by this paper
• Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7

  2004cited by this paper
• Increased expression of interleukin 17 in inflammatory bowel disease

  2003cited by this paper
• Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

  2003cited by this paper
• Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

  1999cited by this paper
• Antibodies to interleukin 12 abrogate established experimental colitis in mice

  1995cited by this paper
• EncephalomyelitisDevelopment of Experimental Autoimmune IL-17 Plays an Important Role in the

  year unknowncited by this paper

• Modulation of gut microbiota and its metabolite Equol by Huaier granule suppresses hepatocellular carcinoma via the gut-liver axis

  2026cites this paper
• The Pathophysiological Significance of Dual Inhibition of IL-17A and IL-17F in Psoriatic Arthritis and Axial Spondyloarthritis

  2026cites this paper
• Exosomes derived from stem cells from apical papilla reduce Th17 cell differentiation and hyposalivation in a murine model of Sjögren's disease.

  2026cites this paper
• RTF1 mediates epigenetic control of Th17 cell differentiation via H2B monoubiquitination.

  2025cites this paper
• Zhilining formula alleviates ulcerative colitis by restricting STAT3 activation and subsequent Th17 cell differentiation.

  2025cites this paper
• Innate Lymphoid Cells in Inflammatory Bowel Disease

  2025cites this paper
• Maternal IL-17A administration fails to disrupt fetal cortical lamination in the absence of maternal microbes

  2025cites this paper
• Activated type 17 helper T cells affect tofacitinib treatment outcomes

  2025cites this paper
• Interplay Between Depression and Inflammatory Bowel Disease: Shared Pathogenetic Mechanisms and Reciprocal Therapeutic Impacts—A Comprehensive Review

  2025cites this paper
• Satb1 directs the differentiation of TH17 cells through suppression of IL-2 expression.

  2025cites this paper
• Supersulfide controls intestinal inflammation by suppressing CD4+ T cell proliferation

  2025cites this paper
• Mitochondria Derived From iPSCs Control by Reciprocal Regulation of Th17/Treg and Anti-Fibrosis

  2025cites this paper
• ENTERIC GLIA PROMOTES THE SURVIVAL OF CD4 AND CD8 T CELLS IN PLEXITIS: A NEW PLAYER IN CROHN'S DISEASE RECURRENCE?

  2025cites this paper
• Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma.

  2025cites this paper
• Appendiceal B Lymphocytes Contribute to the Pathogenesis of Experimental Colitis through Fueling Colonic CD4+ T Polarization.

  2025cites this paper
• Role of mesenchymal stem cells in modulating cytokine networks and immune checkpoints in gastric cancer therapy.

  2025cites this paper
• RORγt Mediates Angiotensin II‐Induced Pressor Responses, Microglia Activation, and Neuroinflammation by Disrupting the Blood–Brain Barrier in Rats

  2025cites this paper
• Epithelial OPA1 links mitochondrial fusion to inflammatory bowel disease.

  2025cites this paper
• Pou2af1 Deficiency Aggravates DSS-Induced Colitis via Impaired Germinal Center Responses and Altered Gut Microbiota.

  2025cites this paper
• Th17 cell pathogenicity in autoimmune disease

  2025cites this paper
• The RORγt ligand-binding domain controls the pathogenicity of IL-17A+ T cells differently in autoimmune diseases of the skin and CNS.

  2025cites this paper
• Identification of the grass carp interleukin-23 receptor and its proinflammatory role in intestinal inflammation.

  2024cites this paper
• Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's disease.

  2024cites this paper
• Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells.

  2024cites this paper
• HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis

  2024cites this paper
• Strategies for targeting cytokines in inflammatory bowel disease

  2024cites this paper
• Gut instinct: harnessing the power of probiotics to tame pathogenic signaling pathways in ulcerative colitis

  2024cites this paper
• Group 3 innate lymphoid cells in intestinal health and disease

  2024cites this paper
• Progress in Study on Pathogenesis of Inflammatory Bowel Disease

  2024cites this paper
• Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine

  2024cites this paper
• A comprehensive immunobiology review of IBD: With a specific glance to Th22 lymphocytes development, biology, function, and role in IBD.

  2024cites this paper
• Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection

  2024cites this paper
• Postbiotic Effect of Escherichia coli CEC15 and Escherichia coli Nissle 1917 on a Murine Model of 5-FU-induced Intestinal Mucositis

  2024cites this paper
• Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells

  2024cites this paper
• Crosstalk between CD8+ T cells and mesenchymal stromal cells in intestine homeostasis and immunity.

  2024cites this paper
• Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis

  2024cites this paper
• Dietary fiber is a critical determinant of pathologic ILC2 responses and intestinal inflammation

  2024cites this paper
• Stability and plasticity of Regulatory T cells in health and disease.

  2024cites this paper
• Th17 Cells: Orchestrators of Mucosal Inflammation and Potential Therapeutic Targets.

  2023cites this paper
• Abnormal generation of IL-17A represses tumor infiltration of stem-like exhausted CD8+ T cells to demote the antitumor immunity

  2023cites this paper
• Exploring Colitis through Dynamic T Cell Adoptive Transfer Models.

  2023cites this paper
• Discovery, structural optimization, and anti-tumor bioactivity evaluations of betulinic acid derivatives as a new type of RORγ antagonists.

  2023cites this paper
• The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors

  2023cites this paper
• Small molecule inhibitors of RORγt for Th17 regulation in inflammatory and autoimmune diseases

  2023cites this paper
• Dysfunction of Foxp3+ Regulatory T Cells Induces Dysbiosis of Gut Microbiota via Aberrant Binding of Immunoglobulins to Microbes in the Intestinal Lumen

  2023cites this paper
• The Development of Systemic Inflammatory Diseases in Hidradenitis Suppurativa

  2023cites this paper
• Targeting the intestinal circadian clock by meal timing ameliorates gastrointestinal inflammation

  2023cites this paper
• Nsun2 coupling with RoRγt shapes the fate of Th17 cells and promotes colitis

  2023cites this paper
• Deletion of miR-150 Prevents Spontaneous T Cell Proliferation and the Development of Colitis

  2023cites this paper
• Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases.

  2023cites this paper
• Lactobacillus rhamnosus MN-431 metabolic tryptophan alleviates complementary food-induced diarrhea through PXR-NF-κB pathway and AHR-Th17 cell response pathways.

  2023cites this paper
• Pathophysiology of Inflammatory Bowel Disease: Innate Immune System

  2023cites this paper
• Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10.

  2023cites this paper
• Circulating levels of cytokines and risk of inflammatory bowel disease: evidence from genetic data

  2023cites this paper
• Topotecan alleviates acetic acid-induced ulcerative colitis in rats via attenuation of the RORγT transcription factor.

  2023cites this paper
• Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity

  2023cites this paper
• Manual cell selection in single cell transcriptomics using scSELpy supports the analysis of immune cell subsets

  2023cites this paper
• T_H17 cell heterogeneity and its role in tissue inflammation

  2023cites this paper
• Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease

  2023cites this paper
• Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

  2023cites this paper
• RORγt expression in mature TH17 cells safeguards their lineage specification by inhibiting conversion to TH2 cells

  2022cites this paper
• The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.

  2022cites this paper
• Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges.

  2022cites this paper
• "Out of the box" new therapeutic strategies for Crohn´s disease: moving beyond biologics.

  2022cites this paper
• ZBTB46 defines and regulates ILC3s that protect the intestine

  2022cites this paper
• TIGIT Deficiency Protects Mice From DSS-Induced Colitis by Regulating IL-17A–Producing CD4+ Tissue-Resident Memory T Cells

  2022cites this paper
• Modulating Regulatory T Cells for Treatment of Glomerulonephritis and Acute Kidney Injury

  2022cites this paper
• Cancer as a Dysfunctional Immune Disorder: Pro-Tumor TH1-like Immune Response and Anti-Tumor THαβ Immune Response Based on the Complete Updated Framework of Host Immunological Pathways

  2022cites this paper
• Gut homeostasis, injury, and healing: New therapeutic targets

  2022cites this paper
• Blockade of IL-23: What is in the Pipeline?

  2022cites this paper
• CCL21 contributes to Th17 cell migration in neuroinflammation in obese mice following lead exposure.

  2022cites this paper
• Gut Microbial Antigenic Mimicry in Autoimmunity

  2022cites this paper
• Inflammatory bowel disease and carcinogenesis

  2022cites this paper
• Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model

  2022cites this paper
• Rap1 prevents colitogenic Th17 cell expansion and facilitates Treg cell differentiation and distal TCR signaling

  2022cites this paper
• A Structured Approach to Optimizing Animal Model Selection for Human Translation: The Animal Model Quality Assessment.

  2022cites this paper
• Psoriasis and Systemic Inflammatory Disorders

  2022cites this paper
• Dual function of fungi-derived cytokines in inflammatory bowel diseases: protection or inflammation

  2022cites this paper
• Lactulose Modulates the Structure of Gut Microbiota and Alleviates Colitis-Associated Tumorigenesis

  2022cites this paper
• STAT signaling in the intestine.

  2021cites this paper
• Practical management of patients on anti-IL17 therapy: Practical guidelines drawn up by the Club Rhumatismes et Inflammation (CRI).

  2021cites this paper
• USP19 Suppresses Th17-Driven Pathogenesis in Autoimmunity

  2021cites this paper
• The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges

  2021cites this paper
• The role of GLS1-mediated glutaminolysis/2-HG/H3K4me3 and GSH/ROS signals in Th17 responses counteracted by PPARγ agonists

  2021cites this paper
• The Role of the IL-23/IL-17 Axis in Disease Initiation in Spondyloarthritis: Lessons Learned From Animal Models

  2021cites this paper
• Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534

  2021cites this paper
• Th17 Cell-Mediated Colitis Is Positively Regulated by Interferon Regulatory Factor 4 in a T Cell-Extrinsic Manner

  2021cites this paper
• Enteric Viruses and Inflammatory Bowel Disease

  2021cites this paper
• Gut Commensal-Induced IκBζ Expression in Dendritic Cells Influences the Th17 Response

  2021cites this paper
• PIR-B Regulates CD4+ IL17a+ T-Cell Survival and Restricts T-Cell–Dependent Intestinal Inflammatory Responses

  2021cites this paper
• Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313.

  2021cites this paper
• Retinoic Acid-Related Orphan Receptor (ROR) Inverse Agonists: Potential Therapeutic Strategies for Multiple Inflammatory Diseases?

  2021cites this paper
• A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells

  2021cites this paper
• Paradoxical Augmentation of Experimental Spondyloarthritis by RORC Inhibition in HLA-B27 Transgenic Rats

  2021cites this paper
• RORγt agonist synergizes with CTLA-4 antibody to inhibit tumor growth through inhibition of Treg cells via TGF-β signaling in cancer.

  2021cites this paper
• RORα is critical for mTORC1 activity in T cell-mediated colitis.

  2021cites this paper
• Dietary Salt Administration Decreases Enterotoxigenic Bacteroides fragilis (ETBF)-Promoted Tumorigenesis via Inhibition of Colonic Inflammation

  2020cites this paper
• Pathogenese chronisch-entzündlicher Darmerkrankungen

  2020cites this paper
• Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease

  2020cites this paper
• Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis

  2020cites this paper